SCHEMBL29598733

SCHEMBL29598733

COC(=O)c1csc(NCC2COC(C)(C)O2)n1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RAB9A P51151 4/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ NAMPT P43490 3/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MAOA P21397 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29598635 0.90 SMN1; SMN2 (0.37) SMN1; SMN2CYP1A2CYP2C19RAB9ANPC1
SCHEMBL29235539 0.89 SMN1; SMN2 (0.39) SMN1; SMN2CYP1A2CYP2C19RAB9ANPC1
SCHEMBL30888336 0.81 SMN1; SMN2 (0.38) SMN1; SMN2CYP1A2CYP2C19RAB9ANPC1
SCHEMBL29708341 0.80 L3MBTL1 (0.45) SMN1; SMN2CA2CYP1A2CYP2C19RAB9A
SCHEMBL30888305 0.79 SMN1; SMN2 (0.36) SMN1; SMN2CYP1A2CYP2C19RAB9ANPC1
SCHEMBL29708577 0.72 USP30 (0.33) —
SCHEMBL29235538 0.67 HRH3 (0.34) SMN1; SMN2MAOAACHEMEN1KMT2A
SCHEMBL12852563 0.67 MAOA (0.55) SMN1; SMN2CA2CYP1A2CYP2C19RAB9A
SCHEMBL29598509 0.66 CYP1A2 (0.44) SMN1; SMN2CYP1A2CYP2C19RAB9ANPC1
SCHEMBL10758430 0.66 SMN1; SMN2 (0.46) SMN1; SMN2CA2RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450283-A 3, 6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their use as pro-apoptotic agents 法国施维雅药厂 2022-05-06 — — CN disclosed
Send feedback